
ORGN Stock Analysis
Origin Materials Inc
BASIC MATERIALS
CHEMICALS
Performance Overview
Trailing adjusted-close returns as of 2026-07-21. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 22, 2026
ORGN Stock Analysis: Why Origin Materials Inc Scored 33% in Stock Value Finder
Understanding Origin Materials Inc (ORGN): A Detailed StockValueFinder Review
Overview of Origin Materials Inc (ORGN)
Origin Materials Inc (ORGN) is a company operating in the basic materials sector, specifically within the chemicals industry. For investors learning how to evaluate stocks systematically, ORGN provides a useful case study in applying fundamental financial metrics. This educational review from StockValueFinder.com examines ORGN's available financial data to help readers understand how professional screening systems assess business quality, financial health, and valuation discipline.
At the time of this analysis, ORGN trades at $1.34 per share. The StockValueFinder system assigned ORGN a score of 33% and a rating of AVOID. This review will explain each component of that assessment, showing readers exactly how to interpret the numbers behind the rating.
Why the StockValueFinder Score Matters
The StockValueFinder score of 33% represents a composite evaluation across multiple financial dimensions. Scores range from 0% to 100%, with higher scores indicating stronger alignment with StockValueFinder's quality-focused screening criteria. A score of 33% places ORGN in the lower third of the scoring spectrum.
The AVOID rating suggests that ORGN does not currently meet StockValueFinder's minimum standards for business quality, financial safety, or valuation discipline. This rating system is designed to help investors focus their research efforts on companies that demonstrate stronger fundamental characteristics.
It's important to understand that a low score or AVOID rating does not predict future stock performance. Rather, it indicates that the company currently fails to meet several important financial screening criteria that StockValueFinder considers when identifying potentially higher-quality investment opportunities.
EPS Strength and Consistency
Earnings per share (EPS) consistency is a fundamental measure of a company's ability to generate profits reliably over time. StockValueFinder looks for companies that demonstrate stable or growing EPS patterns, as this often indicates a durable business model and effective management.
For ORGN, the EPS test result was recorded as "Did not pass." While exact EPS values were not supplied for this analysis, the system's failure to pass this test suggests that ORGN has not demonstrated the level of earnings consistency that StockValueFinder typically requires.
To understand why EPS consistency matters, consider two hypothetical companies
Company A demonstrates steady growth and reliability, while Company B shows volatility and inconsistency. Investors generally prefer the predictability of Company A, as it suggests a more stable business environment and better capital allocation decisions.
When evaluating other stocks, investors should examine EPS trends over multiple years, looking for consistent growth or at least stable performance. Companies with erratic or declining EPS patterns often face greater business risks and may be more vulnerable to economic downturns.
ROIC and Capital Efficiency
Return on invested capital (ROIC) measures how effectively a company uses its capital to generate returns. The formula for ROIC is:
ROIC = Net Operating Profit After Taxes (NOPAT) / Invested Capital
ORGN's ROIC is -189.28%, which represents a significant negative return on the capital invested in the business. StockValueFinder generally prefers to see ROIC of 10% or higher, as this level typically indicates that a company is generating meaningful returns above its cost of capital.
To put ORGN's ROIC in context, consider these examples
Negative ROIC suggests that ORGN is not generating sufficient returns to cover its cost of capital. This could be due to several factors, including low profitability, high capital requirements, or operational inefficiencies. Companies with consistently negative ROIC often struggle to create long-term shareholder value.
When evaluating other stocks, investors should compare ROIC to the company's weighted average cost of capital (WACC). A ROIC higher than WACC generally indicates value creation, while a ROIC lower than WACC suggests value destruction. For ORGN, the -189.28% ROIC clearly indicates significant value destruction at this stage of its development.
Interest Coverage and Financial Safety
Interest coverage measures a company's ability to meet its interest obligations on outstanding debt. The formula is:
Interest Coverage = Earnings Before Interest and Taxes (EBIT) / Interest Expense
StockValueFinder typically prefers interest coverage of 6 or higher, as this level provides a comfortable margin of safety for debt servicing. For ORGN, the interest coverage test result was "Did not pass," indicating that the company does not currently meet this safety threshold.
To understand the importance of interest coverage, consider these examples
While the exact interest coverage ratio for ORGN was not supplied, the failure to pass this test suggests that the company may be facing challenges in servicing its debt obligations. This could indicate higher financial risk, particularly in economic downturns or periods of rising interest rates.
When evaluating other stocks, investors should examine interest coverage trends over time. Improving coverage ratios may indicate strengthening financial health, while declining ratios could signal increasing financial stress. Companies with consistently strong interest coverage ratios generally have more financial flexibility and lower risk of default.
Debt Payback and Balance Sheet Discipline
Debt payback measures how quickly a company could theoretically pay off its debt using its current cash flow. The formula is:
Debt Payback Years = Total Debt / (Net Income + Depreciation + Amortization)
ORGN's debt payback is -0.07 years. While this negative value is unusual, it's important to understand what debt payback generally indicates. StockValueFinder typically prefers debt payback of 3 years or less, as this suggests a company can comfortably manage its debt obligations.
To illustrate debt payback concepts
ORGN's negative debt payback of -0.07 years passed the StockValueFinder test, but this result requires careful interpretation. The negative value suggests that ORGN is not currently generating positive cash flow sufficient to cover its debt obligations. While the system marked this test as passed, investors should understand that negative debt payback is generally not a positive indicator of financial health.
When evaluating other stocks, investors should examine debt payback in conjunction with other leverage metrics. Companies with consistently low debt payback periods generally demonstrate better balance sheet discipline and lower financial risk. However, negative values like ORGN's typically indicate fundamental financial challenges that require further investigation.
P/E Ratio and Valuation Discipline
The price-to-earnings (P/E) ratio measures a company's current share price relative to its earnings per share. The formula is:
P/E Ratio = Market Value per Share / Earnings per Share
ORGN's P/E ratio is -0.03. StockValueFinder generally prefers P/E ratios of 15 or lower for valuation discipline, as lower P/E ratios may indicate more attractive valuations relative to earnings.
To understand P/E ratios, consider these examples
ORGN's negative P/E ratio of -0.03 passed the StockValueFinder test, but this result requires careful interpretation. Negative P/E ratios occur when a company reports negative earnings, making the ratio mathematically negative. While the system marked this test as passed, investors should understand that negative P/E ratios generally indicate unprofitable operations rather than attractive valuations.
When evaluating other stocks, investors should examine P/E ratios in the context of the company's growth prospects, industry norms, and overall business quality. A low P/E ratio is not necessarily attractive if the company faces fundamental business challenges, while a higher P/E ratio may be justified for companies with strong growth potential and durable competitive advantages.
Moving Average Trend and Entry Timing
Moving average trends help investors assess the technical momentum of a stock. StockValueFinder uses moving average signals as part of its timing discipline, though it's important to note that trend analysis is not a predictor of future performance.
For ORGN, the moving average signal is listed as "INSUFFICIENT DATA," with entry signal, entry status, limit buy idea, pullback zone, and risk/trend level all marked as "N/A." This indicates that there is not enough price history or trading volume data available to generate meaningful trend signals.
When evaluating other stocks, investors might see signals such as
It's crucial to understand that moving average signals are tools for timing discipline, not guarantees of future performance. Stocks can reverse direction regardless of their moving average relationships, and technical signals should always be considered alongside fundamental analysis.
For ORGN specifically, the insufficient data means that investors cannot rely on technical signals for timing decisions. This situation is more common with newer public companies or those with lower trading volumes. In such cases, investors must rely more heavily on fundamental analysis and business quality assessments.
Overall Financial Strengths and Weaknesses
Based on the available data, ORGN demonstrates several significant financial challenges
**Strengths:** - Passed the debt payback test (though with a negative value that requires careful interpretation) - Passed the P/E valuation test (though with a negative P/E that indicates unprofitability)
**Weaknesses:** - Did not pass the EPS test, suggesting inconsistent or negative earnings - ROIC of -189.28%, indicating significant value destruction - Did not pass the interest coverage test, suggesting potential debt servicing challenges - Insufficient data for moving average trend analysis
The most concerning aspect of ORGN's financial profile is the combination of negative ROIC and negative P/E ratio. These metrics suggest that the company is currently operating at a loss and destroying value rather than creating it. While some early-stage companies may operate at a loss as they invest in growth, the magnitude of ORGN's negative ROIC (-189.28%) indicates particularly severe capital inefficiency.
Risks and Limitations
When evaluating ORGN or any other stock, it's important to understand the limitations of available data and analysis:
1. **Early-Stage Company Risks:** ORGN may be in the early stages of commercialization, where negative metrics are more common. However, the magnitude of negative ROIC suggests significant challenges.
2. **Data Limitations:** The analysis is based on the supplied data points. Additional financial metrics, industry context, and management quality assessments would provide a more complete picture.
3. **Market and Industry Risks:** The chemicals industry faces regulatory, environmental, and competitive challenges that may impact ORGN's operations.
4. **Timing Considerations:** The moving average signal of "INSUFFICIENT DATA" means investors cannot rely on technical analysis for timing decisions.
5. **Negative Metrics Interpretation:** Negative values for ROIC, P/E ratio, and debt payback require careful interpretation. While some tests may be marked as passed, negative values generally indicate fundamental business challenges.
6. **No Future Predictions:** This analysis is based on current and historical data. It does not predict future financial performance, stock price movements, or business outcomes.
Educational Conclusion
This review of Origin Materials Inc (ORGN) provides a practical case study in applying fundamental financial metrics to stock evaluation. For investors learning how to assess companies systematically, ORGN demonstrates several important lessons:
1. **The Importance of ROIC:** ORGN's -189.28% ROIC illustrates how negative returns on capital can indicate significant business challenges. Investors should look for companies that consistently generate ROIC above their cost of capital.
2. **Understanding Negative Metrics:** Negative P/E ratios and negative debt payback values require careful interpretation. While some tests may be marked as passed, negative values generally indicate unprofitable operations or financial stress.
3. **The Value of Consistency:** The failure to pass the EPS test highlights the importance of earnings consistency. Companies with stable or growing earnings generally demonstrate more durable business models.
4. **Financial Safety Matters:** The failure to pass the interest coverage test suggests potential debt servicing challenges. Companies with strong interest coverage ratios generally have more financial flexibility.
5. **Comprehensive Analysis:** No single metric tells the whole story. ORGN passed some tests but failed others, demonstrating why investors should evaluate multiple financial dimensions.
6. **The Limits of Data:** The "INSUFFICIENT DATA" moving average signal shows that some stocks may not provide enough information for complete analysis. In such cases, investors must rely more heavily on available fundamental data.
7. **Rating Interpretation:** The AVOID rating and 33% score indicate that ORGN does not currently meet StockValueFinder's minimum standards. This rating system helps investors focus their research efforts on companies with stronger fundamental characteristics.
For investors learning how to evaluate stocks, the key takeaway is to examine each financial metric in context, understand what ranges are considered strong or weak, and recognize that no single number tells the whole story. Companies like ORGN that demonstrate multiple negative or weak metrics across different financial dimensions generally face greater business risks and may require more thorough due diligence.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.